TY - JOUR
T1 - Lack of short-chain fatty acids and overgrowth of opportunistic pathogens define dysbiosis of neuromyelitis optica spectrum disorders
T2 - A Chinese pilot study
AU - Gong, Junli
AU - Qiu, Wei
AU - Zeng, Qin
AU - Liu, Xiyuan
AU - Sun, Xiaobo
AU - Li, Huijuan
AU - Yang, Yu
AU - Wu, Aimin
AU - Bao, Jian
AU - Wang, Yuge
AU - Shu, Yaqing
AU - Hu, Xueqiang
AU - Bellanti, Joseph A.
AU - Zheng, Song Guo
AU - Lu, Yongjun
AU - Lu, Zhengqi
N1 - Publisher Copyright:
© The Author(s), 2018.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Background: Intestinal microbiota is an important environmental factor in the initiation and progression of autoimmune diseases. However, investigations on the gut microbiome in neuromyelitis optica spectrum disorders (NMOSD) are relatively insufficient, especially for that of the Asia population. Objectives: To evaluate whether or not the intestinal microbiota of NMOSD patients had specific microbial signatures. Methods: Next-generation sequencing and gas chromatography were employed to compare the fecal microbial composition and short-chain fatty acids (SCFAs) spectrum between patients with NMOSD (n = 84) and healthy controls (n = 54). Results: The gut microbial composition of NMOSD distinguished from healthy individuals. Streptococcus, significantly increased in NMOSD, is positively correlated with disease severities (p < 0.05). The use of immunosuppressants results in a decrease of Streptococcus, suggesting that Streptococcus might play a significant role in the pathogenesis of NMOSD. A striking depletion of fecal SCFAs was observed in NMOSD patients (p < 0.0001), with acetate and butyrate showing significantly negative correlation with disease severities (p < 0.05). Conclusion: The fecal organismal structures and SCFAs level of patients with NMOSD were distinctive from healthy individuals. These findings not only could be critical events driving the aberrant immune response responsible for the pathogenesis of these disorders but could also provide suggestions for disease therapy.
AB - Background: Intestinal microbiota is an important environmental factor in the initiation and progression of autoimmune diseases. However, investigations on the gut microbiome in neuromyelitis optica spectrum disorders (NMOSD) are relatively insufficient, especially for that of the Asia population. Objectives: To evaluate whether or not the intestinal microbiota of NMOSD patients had specific microbial signatures. Methods: Next-generation sequencing and gas chromatography were employed to compare the fecal microbial composition and short-chain fatty acids (SCFAs) spectrum between patients with NMOSD (n = 84) and healthy controls (n = 54). Results: The gut microbial composition of NMOSD distinguished from healthy individuals. Streptococcus, significantly increased in NMOSD, is positively correlated with disease severities (p < 0.05). The use of immunosuppressants results in a decrease of Streptococcus, suggesting that Streptococcus might play a significant role in the pathogenesis of NMOSD. A striking depletion of fecal SCFAs was observed in NMOSD patients (p < 0.0001), with acetate and butyrate showing significantly negative correlation with disease severities (p < 0.05). Conclusion: The fecal organismal structures and SCFAs level of patients with NMOSD were distinctive from healthy individuals. These findings not only could be critical events driving the aberrant immune response responsible for the pathogenesis of these disorders but could also provide suggestions for disease therapy.
UR - http://www.scopus.com/inward/record.url?scp=85052560485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052560485&partnerID=8YFLogxK
U2 - 10.1177/1352458518790396
DO - 10.1177/1352458518790396
M3 - Article
C2 - 30113252
AN - SCOPUS:85052560485
SN - 1352-4585
VL - 25
SP - 1316
EP - 1325
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
IS - 9
ER -